Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
VERA · NASDAQ · Pharmaceutical Preparations
$25.45−1.30 (−4.86%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Vera Therapeutics (VERA) · oqro.io/stocks/VERA · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 16, 2026
T. Rowe Price Associates, Inc. cut its VERA stake below 5% (3.8%)SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Deep Track Capital, LP disclosed a reduced position in VERA for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Avoro Capital Advisors LLC disclosed a reduced position in VERA for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Frontier Capital Management Co LLC disclosed an increased position in VERA for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Deerfield Management Company, L.P. disclosed an increased position in VERA for Q2 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Deep Track Capital, LP disclosed an increased position in VERA for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Orbimed Advisors LLC disclosed an increased position in VERA for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Deerfield Management Company, L.P. disclosed a reduced position in VERA for Q1 2026SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Mar 16, 2026
Avoro Capital Advisors LLC disclosed a reduced position in VERA for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Bellevue Group AG disclosed a new position in VERA for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Orbimed Advisors LLC disclosed a new position in VERA for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Deerfield Management Company, L.P. disclosed an increased position in VERA for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Deep Track Capital, LP disclosed a new position in VERA for Q4 2025Fund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Avoro Capital Advisors LLC disclosed a reduced position in VERA for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Deerfield Management Company, L.P. disclosed an increased position in VERA for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 13, 2025
Siren, L.L.C. no longer reported VERA for Q3 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Orbimed Advisors LLC no longer reported VERA for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Samlyn Capital, LLC no longer reported VERA for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Deerfield Management Company, L.P. disclosed an increased position in VERA for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Avoro Capital Advisors LLC disclosed an increased position in VERA for Q2 2025Insider trade · Traded Jun 23, 2025 · Filed Jun 26, 2025
Director purchased ~$2.91M of VERA shares in the open marketSourceInsider trade · Traded Jun 23, 2025 · Filed Jun 26, 2025
Director purchased ~$1.46M of VERA shares in the open marketSourceInsider trade · Traded Jun 24, 2025 · Filed Jun 26, 2025
Director purchased ~$605K of VERA shares in the open marketSourceInsider trade · Traded Jun 24, 2025 · Filed Jun 26, 2025
Director purchased ~$303K of VERA shares in the open marketSourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 23, 2025
Siren, L.L.C. disclosed a reduced position in VERA for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Deerfield Management Company, L.P. disclosed a new position in VERA for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Avoro Capital Advisors LLC disclosed an increased position in VERA for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Paradigm Biocapital Advisors LP no longer reported VERA for Q1 2025Insider trade · Traded Feb 21, 2025 · Filed Feb 27, 2025
CEO sold ~$296K of VERA shares in the open marketSourceInsider trade · Traded Feb 26, 2025 · Filed Feb 27, 2025
CEO sold ~$220K of VERA shares in the open marketSourceInsider trade · Traded Feb 26, 2025 · Filed Feb 27, 2025
CEO sold ~$31K of VERA shares in the open marketSourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Avoro Capital Advisors LLC disclosed an increased position in VERA for Q4 2024SourceInsider trade · Traded Jan 8, 2025 · Filed Jan 10, 2025
CEO sold ~$414K of VERA shares in the open marketSourceInsider trade · Traded Jan 8, 2025 · Filed Jan 10, 2025
CEO sold ~$237K of VERA shares in the open marketSourceInsider trade · Traded Jan 8, 2025 · Filed Jan 10, 2025
CEO sold ~$79K of VERA shares in the open marketSourceInsider trade · Traded Dec 18, 2024 · Filed Dec 20, 2024
CEO sold ~$219K of VERA shares in the open marketSourceInsider trade · Traded Dec 18, 2024 · Filed Dec 20, 2024
CEO sold ~$204K of VERA shares in the open marketSourceInsider trade · Traded Dec 18, 2024 · Filed Dec 20, 2024
CEO sold ~$156K of VERA shares in the open marketSourceInsider trade · Traded Dec 18, 2024 · Filed Dec 20, 2024
CEO sold ~$93K of VERA shares in the open marketSourceInsider trade · Traded Nov 25, 2024 · Filed Nov 27, 2024
CEO sold ~$369K of VERA shares in the open marketSourceInsider trade · Traded Nov 25, 2024 · Filed Nov 27, 2024
CEO sold ~$310K of VERA shares in the open marketSourceInsider trade · Traded Nov 25, 2024 · Filed Nov 27, 2024
CEO sold ~$91K of VERA shares in the open marketSourceInsider trade · Traded Nov 25, 2024 · Filed Nov 27, 2024
CEO sold ~$92K of VERA shares in the open marketSourceInsider trade · Traded Oct 28, 2024 · Filed Oct 30, 2024
Director sold ~$710K of VERA shares in the open marketSourceInsider trade · Traded Oct 28, 2024 · Filed Oct 30, 2024
Director sold ~$10K of VERA shares in the open marketSourceInsider trade · Traded Oct 23, 2024 · Filed Oct 25, 2024
CEO sold ~$506K of VERA shares in the open marketSourceInsider trade · Traded Oct 23, 2024 · Filed Oct 25, 2024
CEO sold ~$158K of VERA shares in the open marketSourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 13, 2025
Siren, L.L.C. disclosed a reduced position in VERA for Q2 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Samlyn Capital, LLC disclosed a reduced position in VERA for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Orbimed Advisors LLC disclosed a reduced position in VERA for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Holocene Advisors, LP disclosed an increased position in VERA for Q1 2025SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Paradigm Biocapital Advisors LP disclosed an increased position in VERA for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Samlyn Capital, LLC disclosed an increased position in VERA for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Siren, L.L.C. disclosed a reduced position in VERA for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Orbimed Advisors LLC disclosed an increased position in VERA for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Holocene Advisors, LP disclosed a reduced position in VERA for Q4 2024SourceInsider trade · Traded Dec 18, 2024 · Filed Dec 20, 2024
CEO sold ~$82K of VERA shares in the open marketSourceInsider trade · Traded Dec 11, 2024 · Filed Dec 13, 2024
CEO sold ~$700K of VERA shares in the open marketSourceInsider trade · Traded Dec 11, 2024 · Filed Dec 13, 2024
CEO sold ~$83K of VERA shares in the open marketSourceInsider trade · Traded Dec 11, 2024 · Filed Dec 13, 2024
CEO sold ~$33K of VERA shares in the open marketSourceInsider trade · Traded Dec 11, 2024 · Filed Dec 13, 2024
CEO sold ~$4.8K of VERA shares in the open marketSourceInsider trade · Traded Nov 25, 2024 · Filed Nov 27, 2024
CEO sold ~$67K of VERA shares in the open marketSourceInsider trade · Traded Nov 13, 2024 · Filed Nov 15, 2024
CEO sold ~$605K of VERA shares in the open marketSourceInsider trade · Traded Nov 13, 2024 · Filed Nov 15, 2024
CEO sold ~$368K of VERA shares in the open marketSourceInsider trade · Traded Nov 13, 2024 · Filed Nov 15, 2024
CEO sold ~$166K of VERA shares in the open marketSourceInsider trade · Traded Nov 13, 2024 · Filed Nov 15, 2024
CEO sold ~$93K of VERA shares in the open marketSourceInsider trade · Traded Nov 13, 2024 · Filed Nov 15, 2024
CEO sold ~$93K of VERA shares in the open marketSourceInsider trade · Traded Nov 13, 2024 · Filed Nov 15, 2024
CEO sold ~$93K of VERA shares in the open marketSourceInsider trade · Traded Nov 13, 2024 · Filed Nov 15, 2024
CEO sold ~$78K of VERA shares in the open marketSourceInsider trade · Traded Nov 13, 2024 · Filed Nov 15, 2024
CEO sold ~$16K of VERA shares in the open marketSourceInsider trade · Traded Nov 13, 2024 · Filed Nov 15, 2024
CEO sold ~$5.1K of VERA shares in the open marketSourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Paradigm Biocapital Advisors LP disclosed a new position in VERA for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Samlyn Capital, LLC disclosed an increased position in VERA for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Holocene Advisors, LP disclosed an increased position in VERA for Q3 2024SourceInsider trade · Traded Oct 23, 2024 · Filed Oct 25, 2024
CEO sold ~$94K of VERA shares in the open marketSourceInsider trade · Traded Oct 23, 2024 · Filed Oct 25, 2024
CEO sold ~$25K of VERA shares in the open marketSourceInsider trade · Traded Oct 9, 2024 · Filed Oct 11, 2024
CEO sold ~$467K of VERA shares in the open marketSourceInsider trade · Traded Oct 9, 2024 · Filed Oct 11, 2024
CEO sold ~$130K of VERA shares in the open marketSource